BRISTOL MYERS SQUIBB CO Earnings Per Share Disclosure
| Year Ended December 31, | |||||||||||||||||
| Amounts in millions, except per share data | 2025 | 2024 | 2023 | ||||||||||||||
| Net earnings/(loss) attributable to BMS | $ | 7,054 | $ | (8,948) | $ | 8,025 | |||||||||||
| Weighted-average common shares outstanding - basic | 2,034 | 2,027 | 2,069 | ||||||||||||||
| Incremental shares attributable to share-based compensation plans | 5 | — | 9 | ||||||||||||||
| Weighted-average common shares outstanding - diluted | 2,039 | 2,027 | 2,078 | ||||||||||||||
| Earnings/(Loss) per common share | |||||||||||||||||
| Basic | $ | 3.47 | $ | (4.41) | $ | 3.88 | |||||||||||
| Diluted | 3.46 | (4.41) | 3.86 | ||||||||||||||
Historical Timeline
| Fiscal Year | Filed | |
|---|---|---|
| 2025 | Feb 11, 2026 | Showing above |
| 2024 | Feb 12, 2025 | |
| 2023 | Feb 13, 2024 | |
| 2022 | Feb 14, 2023 | |
| 2021 | Feb 9, 2022 | |
| 2020 | Feb 10, 2021 | |
| 2019 | Feb 24, 2020 | |
| 2018 | Feb 25, 2019 | |
| 2017 | Feb 13, 2018 | |
| 2016 | Feb 21, 2017 | |
| 2015 | Feb 12, 2016 | |
About Earnings Per Share Disclosures
The earnings per share disclosure breaks down the calculation from net income to both basic and diluted EPS, revealing the full impact of a company's capital structure on per-share economics. The reconciliation between basic and diluted share counts exposes how many stock options, RSUs, convertible securities, and warrants are potentially dilutive to existing shareholders.
Key signals: a widening gap between basic and diluted shares indicates growing dilution from equity compensation or convertible instruments. Anti-dilutive securities excluded from the diluted calculation deserve attention — they represent latent dilution that will materialize if the stock price rises. Watch for the effect of share buybacks on per-share metrics: EPS growth driven primarily by repurchases rather than income growth signals weakening fundamentals. Compare year-over-year changes in the diluted share count against equity compensation expense to assess whether management is effectively managing dilution.